Literature DB >> 16371324

Role of the JAKs/STATs pathway in the intracellular calcium changes induced by interleukin-6 in hippocampal neurons.

D I Orellana1, R A Quintanilla, C Gonzalez-Billault, R B Maccioni.   

Abstract

Recent studies show that inflammation has an active role in the onset of neurodegenerative diseases. It is known that in response to extracellular insults microglia and/or astrocytes produce inflammatory agents. These contribute to the neuropathological events in the aging process and neuronal degeneration. Interleukin-6 (IL-6) has been involved in the pathogenesis of neurodegenerative disorders, such as Alzheimer's and Parkinson's diseases. Here, we show that IL-6 treatment of rat hippocampal neurons increases the calcium influx via NMDA-receptor, an effect that is prevented by the specific NMDA receptor antagonist MK-801 (dizocilpine). We also show that this calcium influx is mediated by the JAKs/STATs pathway, since the inhibitor of JAKs/STATs pathway, JAK 3 inhibitor, blocks calcium influx even in the presence of IL-6. This increase in calcium signal was dependent on external sources, since this signal was not observed in the presence of EGTA. Additional studies indicate that the increase in cytosolic calcium induces tau protein hyperphosphorylation, as revealed by using specific antibodies against Alzheimer phosphoepitopes. This anomalous tau hyperphosphorylation was dependent on both the JAKs/STATs pathway and NMDA receptor. These results suggest that IL-6 would induce a cascade of molecular events that produce a calcium influx through NMDA receptors, mediated by the JAKs/STATs pathway, which subsequently modifies the tau hyperphosphorylation patterns.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16371324     DOI: 10.1007/BF03033983

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  47 in total

Review 1.  Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty.

Authors:  W B Ershler; E T Keller
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

Review 2.  Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease.

Authors:  Frank M LaFerla
Journal:  Nat Rev Neurosci       Date:  2002-11       Impact factor: 34.870

3.  Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

Authors:  D Blum-Degen; T Müller; W Kuhn; M Gerlach; H Przuntek; P Riederer
Journal:  Neurosci Lett       Date:  1995-12-29       Impact factor: 3.046

4.  Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology.

Authors:  G Mehlhorn; M Hollborn; R Schliebs
Journal:  Int J Dev Neurosci       Date:  2000 Jul-Aug       Impact factor: 2.457

5.  Increased gene expression of interleukin-1alpha and interleukin-6 in rat primary glial cells induced by beta-amyloid fragment.

Authors:  V C Toro; R Tehranian; M Zetterström; G Eriksson; U Langel; T Bartfai; K Iverfeld
Journal:  J Mol Neurosci       Date:  2001-12       Impact factor: 3.444

6.  Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain.

Authors:  M Minami; Y Kuraishi; M Satoh
Journal:  Biochem Biophys Res Commun       Date:  1991-04-30       Impact factor: 3.575

7.  Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons.

Authors:  Z Qiu; D D Sweeney; J G Netzeband; D L Gruol
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

8.  Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo?

Authors:  Krishnan Sriram; Stanley A Benkovic; Meleik A Hebert; Diane B Miller; James P O'Callaghan
Journal:  J Biol Chem       Date:  2004-03-02       Impact factor: 5.157

9.  Interleukin-6 is elevated in plasma in multiple sclerosis.

Authors:  K Frei; S Fredrikson; A Fontana; H Link
Journal:  J Neuroimmunol       Date:  1991-02       Impact factor: 3.478

10.  Interleukin 6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role in hypergammaglobulinemia.

Authors:  G E Grau; K Frei; P F Piguet; A Fontana; H Heremans; A Billiau; P Vassalli; P H Lambert
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

View more
  27 in total

1.  Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease.

Authors:  Leonel E Rojo; Jans Alzate-Morales; Iván N Saavedra; Peter Davies; Ricardo B Maccioni
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  Ciliary neurotrophic factor signaling in the rat orbitofrontal cortex ameliorates stress-induced deficits in reversal learning.

Authors:  Milena Girotti; Jeri D Silva; Christina M George; David A Morilak
Journal:  Neuropharmacology       Date:  2019-09-22       Impact factor: 5.250

3.  Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms.

Authors:  Christian A Di Buduo; Vittorio Abbonante; Caroline Marty; Francesco Moccia; Elisa Rumi; Daniela Pietra; Paolo M Soprano; Dmitry Lim; Daniele Cattaneo; Alessandra Iurlo; Umberto Gianelli; Giovanni Barosi; Vittorio Rosti; Isabelle Plo; Mario Cazzola; Alessandra Balduini
Journal:  Blood       Date:  2020-01-09       Impact factor: 22.113

4.  Trans-resveratrol attenuates high fatty acid-induced P2X7 receptor expression and IL-6 release in PC12 cells: possible role of P38 MAPK pathway.

Authors:  Hong Xu; Chaopeng Xiong; Luling He; Bing Wu; Lulu Peng; Yajun Cheng; Fuqing Jiang; Liping Tan; Lan Tang; Yunming Tu; Yuping Yang; Changle Liu; Yun Gao; Guilin Li; Chunping Zhang; Shuangmei Liu; Changshui Xu; Hong Wu; Guodong Li; Shangdong Liang
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

Review 5.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 6.  Potential Role of Extracellular CIRP in Alcohol-Induced Alzheimer's Disease.

Authors:  Archna Sharma; Max Brenner; Ping Wang
Journal:  Mol Neurobiol       Date:  2020-08-21       Impact factor: 5.590

Review 7.  Ethanol and Cytokines in the Central Nervous System.

Authors:  Marisa Roberto; Reesha R Patel; Michal Bajo
Journal:  Handb Exp Pharmacol       Date:  2018

8.  Upregulation of excitatory amino acid transporters by coexpression of Janus kinase 3.

Authors:  Jamshed Warsi; Dong Luo; Bernat Elvira; Kashif Jilani; Ekaterina Shumilina; Zohreh Hosseinzadeh; Florian Lang
Journal:  J Membr Biol       Date:  2014-06-14       Impact factor: 1.843

Review 9.  Growth hormone and cognitive function.

Authors:  Fred Nyberg; Mathias Hallberg
Journal:  Nat Rev Endocrinol       Date:  2013-04-30       Impact factor: 43.330

10.  Inactivation of JAK2/STAT3 signaling axis and downregulation of M1 mAChR cause cognitive impairment in klotho mutant mice, a genetic model of aging.

Authors:  Seok-Joo Park; Eun-Joo Shin; Sun Seek Min; Jihua An; Zhengyi Li; Yoon Hee Chung; Ji Hoon Jeong; Jae-Hyung Bach; Seung-Yeol Nah; Won-Ki Kim; Choon-Gon Jang; Yong-Sun Kim; Yo-Ichi Nabeshima; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Neuropsychopharmacology       Date:  2013-02-06       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.